STOCK TITAN

Fosun Develops Business for Good and Creates IMPACT

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Fosun International (FOSUY) has released its 2024 ESG Report and third Climate Information Disclosures Report, highlighting its commitment to sustainable development. The company maintained an MSCI ESG rating of AA and ranked in the top 5% among global peers in S&P Global's Corporate Sustainability Assessment.

The company has established concrete climate goals, aiming to peak carbon emissions by 2028 and achieve carbon neutrality by 2050. Notable achievements include completing a USD888 million sustainability-linked syndicated loan and maintaining LEED Platinum certification for the Bund Finance Center in Shanghai.

In healthcare innovation, Fosun's anticancer drug HANSIZHUANG received EU approval for small cell lung cancer treatment, while their artesunate injection has treated over 80 million severe malaria patients globally. The company's total assets reached RMB796.5 billion as of December 2024.

Fosun International (FOSUY) ha pubblicato il suo Rapporto ESG 2024 e il terzo Rapporto sulle Informazioni Climatiche, sottolineando il suo impegno per lo sviluppo sostenibile. L'azienda ha mantenuto un rating ESG MSCI di AA e si è posizionata tra il top 5% dei suoi pari a livello globale nella Corporate Sustainability Assessment di S&P Global.

La società ha fissato obiettivi climatici concreti, puntando a raggiungere il picco delle emissioni di carbonio entro il 2028 e la neutralità carbonica entro il 2050. Tra i risultati più significativi, il completamento di un prestito sindacato legato alla sostenibilità da 888 milioni di USD e il mantenimento della certificazione LEED Platinum per il Bund Finance Center di Shanghai.

Nel campo dell’innovazione sanitaria, il farmaco antitumorale HANSIZHUANG di Fosun ha ottenuto l’approvazione dell’UE per il trattamento del carcinoma polmonare a piccole cellule, mentre l’iniezione di artesunato ha curato oltre 80 milioni di pazienti con malaria grave in tutto il mondo. Al dicembre 2024, il totale degli attivi della società ha raggiunto i 796,5 miliardi di RMB.

Fosun International (FOSUY) ha publicado su Informe ESG 2024 y su tercer Informe de Divulgación de Información Climática, destacando su compromiso con el desarrollo sostenible. La compañía mantuvo una calificación ESG MSCI de AA y se ubicó en el 5% superior entre sus pares globales en la Evaluación de Sostenibilidad Corporativa de S&P Global.

La empresa ha establecido metas climáticas concretas, con el objetivo de alcanzar el pico de emisiones de carbono para 2028 y lograr la neutralidad de carbono para 2050. Entre los logros destacados está la finalización de un préstamo sindicado vinculado a la sostenibilidad por USD 888 millones y mantener la certificación LEED Platinum para el Bund Finance Center en Shanghái.

En innovación sanitaria, el medicamento anticancerígeno HANSIZHUANG de Fosun recibió la aprobación de la UE para el tratamiento del cáncer de pulmón de células pequeñas, mientras que su inyección de artesunato ha tratado a más de 80 millones de pacientes con malaria grave en todo el mundo. Los activos totales de la compañía alcanzaron 796,5 mil millones de RMB en diciembre de 2024.

푸순 인터내셔널(FOSUY)은 2024년 ESG 보고서 및 세 번째 기후 정보 공시 보고서를 발표하며 지속 가능한 발전에 대한 의지를 강조했습니다. 회사는 MSCI ESG AA 등급을 유지했으며, S&P 글로벌의 기업 지속 가능성 평가에서 전 세계 동종 업체 중 상위 5%에 랭크되었습니다.

회사는 2028년까지 탄소 배출량 정점 도달, 2050년까지 탄소 중립 달성이라는 구체적인 기후 목표를 설정했습니다. 주요 성과로는 8억 8,800만 달러 규모의 지속 가능성 연계 신디케이트 대출 완료와 상하이 번드 파이낸스 센터의 LEED 플래티넘 인증 유지가 있습니다.

의료 혁신 분야에서는 푸순의 항암제 HANSIZHUANG이 소세포 폐암 치료를 위해 EU 승인을 받았으며, 아르테수네이트 주사는 전 세계 중증 말라리아 환자 8,000만 명 이상을 치료했습니다. 2024년 12월 기준 회사 총자산은 7,965억 위안에 달했습니다.

Fosun International (FOSUY) a publié son rapport ESG 2024 ainsi que son troisième rapport sur les informations climatiques, mettant en avant son engagement en faveur du développement durable. L’entreprise a conservé une note ESG MSCI de AA et s’est classée parmi les 5 % des meilleures entreprises mondiales selon l’évaluation de durabilité d’entreprise de S&P Global.

L’entreprise a fixé des objectifs climatiques concrets, visant à atteindre le pic des émissions de carbone d’ici 2028 et la neutralité carbone d’ici 2050. Parmi ses réalisations notables figurent la finalisation d’un prêt syndiqué lié à la durabilité de 888 millions de dollars et le maintien de la certification LEED Platinum pour le Bund Finance Center de Shanghai.

Dans le domaine de l’innovation en santé, le médicament anticancéreux HANSIZHUANG de Fosun a obtenu l’approbation de l’UE pour le traitement du cancer du poumon à petites cellules, tandis que leur injection d’artésunate a traité plus de 80 millions de patients atteints de paludisme sévère dans le monde. Au 31 décembre 2024, le total des actifs de l’entreprise atteignait 796,5 milliards de RMB.

Fosun International (FOSUY) hat seinen ESG-Bericht 2024 sowie den dritten Bericht zur Klimainformation veröffentlicht und damit sein Engagement für nachhaltige Entwicklung hervorgehoben. Das Unternehmen behielt eine MSCI ESG-Bewertung von AA bei und gehörte laut der Corporate Sustainability Assessment von S&P Global zu den besten 5 % seiner globalen Wettbewerber.

Das Unternehmen hat konkrete Klimaziele gesetzt, mit dem Ziel, bis 2028 den Höhepunkt der CO2-Emissionen zu erreichen und bis 2050 Klimaneutralität zu erzielen. Zu den bemerkenswerten Erfolgen zählen die Durchführung eines nachhaltigkeitsgebundenen syndizierten Kredits in Höhe von 888 Millionen USD sowie die Beibehaltung der LEED-Platinum-Zertifizierung für das Bund Finance Center in Shanghai.

Im Bereich der medizinischen Innovation erhielt Fosuns Krebsmedikament HANSIZHUANG die EU-Zulassung zur Behandlung von kleinzelligem Lungenkrebs, während ihre Artesunat-Injektion weltweit über 80 Millionen schwere Malaria-Patienten behandelt hat. Die Gesamtvermögenswerte des Unternehmens beliefen sich im Dezember 2024 auf 796,5 Milliarden RMB.

Positive
  • Maintained MSCI ESG rating of AA and ranked in top 5% among global peers
  • Secured USD888 million sustainability-linked syndicated loan
  • HANSIZHUANG received EU approval for cancer treatment
  • Artesunate injection treated over 80 million malaria patients globally
  • Total assets reached RMB796.5 billion
Negative
  • None.

Releases 2024 ESG Report and the Third Climate Information Disclosures Report

HONG KONG, April 25, 2025 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), issued the Environmental, Social and Governance (ESG) Report 2024 (the "ESG Report"). Facing the increasingly severe challenges of global climate change, Fosun released its third Climate Information Disclosures Report with reference to the Part D of Appendix C2 of the Main Board Listing Rules (the "New Climate Requirements") of the Hong Kong Stock Exchange, the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations and International Financial Reporting Standards S2 Climate-related Disclosures Requirements ("IFRS S2").

With the original aspiration of "Self-improvement, Teamwork, Performance, and Contribution to Society", Fosun firmly believes in its commitment to developing business for good. While strengthening its business operations, Fosun continuously refines its sustainable development strategy to address changes in the global economy, society, and environment, ensuring long-term competitiveness while creating social value. Last year, Fosun formulated its sustainable development strategy, focusing on six key directions under "Create IMPACT", which stands for I: Innovation-driven, M: Mindful Operation, P: People and Partner Oriented, A: Advanced Governance, C: Climate and Planet Positive and T: Transparency.

Actively driving global sustainable development and achieving outstanding ESG ratings

In 2024, Fosun continued to focus on its core businesses. By leveraging its increasingly sophisticated global business presence, it operated responsibly across more than 35 countries and regions, actively contributing to public welfare and creating sustainable value worldwide. Fosun has long been dedicated to philanthropy projects in areas such as rural revitalization, healthcare, educational equity, community construction, culture and art, significantly expanding its impact across global communities and striving to build a more responsible, inclusive and sustainable future.

As a responsible global citizen, Fosun officially joined the United Nations Global Compact ("UN Global Compact") in 2014. It fully supports the ten principles of the UN Global Compact on human rights, labor, environment and anti-corruption, and has deeply integrated these principles into its "Create IMPACT" sustainable development strategy and code of conduct. Over the past year, despite the global environmental, social and economic uncertainties, Fosun remained committed to sustainable development, diligently upholding its long-term commitments in key areas of sustainable development, and achieving good results. Fosun International maintained an MSCI ESG rating of AA, achieved an HSI ESG rating of AA-, ranked in the top 5% among global peers in latest S&P Global's Corporate Sustainability Assessment (CSA), was included in S&P Global's Sustainability Yearbook 2025, and was selected as the top 1% in S&P Global's Sustainability Yearbook (China Edition).

Actively responding to climate change and promoting low-carbon transformation

In response to climate change, the Group has transitioned from passive adaptation to active participation and innovation. At the top-level organizational structure, under the guidance of the Board of Directors (the "Board") and the Carbon Neutrality Committee, Fosun International has achieved several key phased goals, such as incorporating carbon neutrality indicators into the performance appraisal of the management, establishing a carbon emission management system and audit standards, and conducting greenhouse gas inventory training across the Group. In terms of technology-driven low-carbon transformation, the Group has accelerated the adoption of low-carbon technologies, leveraging innovative technologies to drive the low-carbon transformation of the industrial chain and provide consumers with more sustainable products and services. In terms of financial innovation, in 2024, the Group successfully completed a sustainability-linked syndicated loan amounting to USD888 million, ranking among the top in similar loans for Chinese private enterprises. This achievement has effectively supported the implementation of the Group's sustainable development strategy.

Fosun actively responds to the national "dual carbon" goals by promoting carbon neutrality and energy conservation and emission reduction. In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement. As 2024 marked the final year before Hong Kong Stock Exchange's New Climate Requirements came into effect, Fosun International proactively aligned with international standards such as TCFD and IFRS S2, and released its third Climate Information Disclosures Report, enhancing the transparency of its climate actions and demonstrating its commitment to ongoing efforts in this area.

The Group also actively encourages its member companies to carry out climate actions. The Bund Finance Center (BFC), the Group's base in Shanghai and a landmark in Shanghai, was awarded the LEED Platinum certification, which is hailed as the "Oscar Award" in the green building industry, with a score of 97 points to set a new world record in 2022. During the reporting period, BFC maintained the LEED Platinum certification, showcasing BFC's exceptional commitment to green building practices and promoting low-carbon sustainable development. In August 2024, BFC was successfully included in Shanghai's first batch of carbon peaking and carbon neutrality pilot demonstration projects, becoming the only large-scale commercial complex exceeding 200,000 square meters on the list.

In 2024, Fosun Insurance Portugal (Fidelidade) participated in the 29th session of the Conference of the Parties (COP29) to the United Nations Framework Convention on Climate Change for the second consecutive year to discuss climate change response strategies and corporate responsibilities with industry peers. During the COP29, Fosun Insurance Portugal launched the Impact Center for Climate Change (ICCC), a platform for the study, research and sharing of knowledge with society. The ICCC promotes knowledge production in the field of climate risks and helps the insurance industry enhance its capacity to address climate change.

Leveraging innovation to actively contribute to society

Fosun adheres to the innovation-driven strategy, and the anticancer and antimalarial drugs developed by its health industries have widely benefited cancer patients and severe malaria patients. Henlius' innovative drug, HANSIZHUANG (serplulimab injection), an anti-PD-1 monoclonal antibody, was approved for marketing in the European Union in early 2025. This milestone makes it the first and only PD-1 innovative drug approved for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) in the European Union. As of the end of 2024, Fosun Pharma's independently developed artesunate for injection had saved more than 80 million severe malaria patients worldwide, with more than 400 million doses supplied globally.

In the Chinese mainland, Fosun Kairos' first CAR-T cell therapy product, Yi Kai Da (ejilunsai injection), had benefited over 800 lymphoma patients as of the end of 2024. Additionally, Intuitive Fosun's Ion Robotic Bronchoscopy ("Ion System") was approved by the National Medical Products Administration in 2024. Fosun has been actively fostering global win-win cooperation to enhance the accessibility and affordability of medical technologies, ensuring that more patients can benefit.

In order to better promote the fulfilment and implementation of corporate social responsibility, Fosun Foundation was established in 2012. It has been making unremitting efforts in the fields of global emergency relief, rural revitalization, health, education, culture and art, youth development, etc. to create social value. Among these initiatives, the Rural Doctors Program has supported 25,000 rural doctors and benefited 3 million rural families since its launch in 2017. Moreover, the "Rural Doctors Program Empowering Rural Medical Services" was included in the "20 Cases of Private Sector's Sustainable Development in China for 20 Years" Report of the UN Global Compact.

Regarding youth entrepreneurship and development, under the principle of "Innovation and People-oriented Development", Fosun Foundation, in collaboration with Fidelidade and Portugal's healthcare group Luz Saúde, launched the sustainable innovation project "Protechting Global Youth Innovation and Entrepreneurship Competition" in early 2016. Since 2018, the Protechting competition has incubated 40 pilot projects and led to 5 commercial collaborations. On 9 April 2025, the 7th Protechting Global Youth Innovation and Entrepreneurship Competition took place in Lisbon, the capital of Portugal, where the top four finalists were announced. In May 2025, these four teams will visit Shanghai, Macau, Shenzhen, and Hong Kong for exchanges and roadshows, while also seeking potential business collaboration opportunities. Over the past seven years, the Protechting competition has expanded from Portugal to Europe and now to China and beyond, becoming an international platform for technology innovation exchange that connects young people from different cultures and continents.

Linking ESG performance to Board appraisal through a top-down, long-term ESG mechanism

Fosun has established a top-down and long-term mechanism for ESG improvement and has included ESG management performance as an evaluation factor in the Executive Directors' performance assessment, and the ESG management performance appraisal mechanism is also extended to the CEOs of the Group and the personnel in charge of each business group. Fosun has set up an ESG Board Committee under the Board to assist the Board in guiding and overseeing the Group's ESG development and implementation. At the management and decision level, Fosun has established an ESG Executive Committee under the management to provide decision support for the implementation of ESG strategies. At the implementation level, the Group has also set up an ESG Management Committee and an ESG Working Group to implement ESG strategies and related actions and ensure the establishment of appropriate and effective ESG risk management and internal control system.

Looking ahead, Fosun will continue to keep abreast of the development of the global sustainable development field, refine and enhance Fosun's ESG management, actively respond to national strategies, implement "dual carbon" goals, promote rural revitalization, expand impact across global communities in areas such as healthcare, educational equity, community construction, culture and art. In operational management, Fosun will continue to promote initiatives such as ensuring information security, promoting technology innovation, and protecting employees' rights and interests, which collectively drive the integration of sustainable practices and value creation. Leveraging the resources and advantages of Fosun's global industrial ecosystem, Fosun endeavours to create a positive impact on sustainable development and continuously create a better world.

- End -

For more information on Fosun's ESG, please refer to Fosun International's ESG Report 2024 posted on the Hong Kong Stock Exchange's website (http://www.hkexnews.hk)
or the Company's ESG webpage (https://en.fosun.com/esg/)
The electronic copy of the 2024 Climate Information Disclosures Report is available on the Company's ESG webpage: (https://en.fosun.com/esg/)

About Fosun

Fosun was founded in 1992. After more than 30 years of development, Fosun has become a global innovation-driven consumer group. Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of families worldwide in Health, Happiness, and Wealth. In 2007, Fosun International was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2024, Fosun International's total assets amounted to RMB796.5 billion and it received an AA MSCI ESG rating.

Cision View original content:https://www.prnewswire.com/news-releases/fosun-develops-business-for-good-and-creates-impact-302438401.html

SOURCE Fosun

FAQ

What are Fosun International's (FOSUY) carbon neutrality targets for 2028 and 2050?

Fosun aims to peak carbon emissions by 2028 and achieve complete carbon neutrality by 2050, aligning with the 1.5°C temperature control target set in the Paris Agreement.

How much was Fosun's (FOSUY) sustainability-linked loan in 2024?

Fosun completed a sustainability-linked syndicated loan of USD888 million in 2024, ranking among the top in similar loans for Chinese private enterprises.

What are the key achievements of Fosun's (FOSUY) healthcare innovations in 2024?

HANSIZHUANG received EU approval for small cell lung cancer treatment, and their artesunate injection has treated over 80 million severe malaria patients globally.

What was Fosun International's (FOSUY) total asset value as of December 2024?

Fosun International's total assets amounted to RMB796.5 billion as of December 31, 2024.
Fosun Internatio

OTC:FOSUY

FOSUY Rankings

FOSUY Latest News

FOSUY Stock Data

5.14B
2.44B
Conglomerates
Industrials
Link
Hong Kong
Central